CN101304750A - 用于治疗肉芽肿性酒糟鼻的阿奇霉素 - Google Patents

用于治疗肉芽肿性酒糟鼻的阿奇霉素 Download PDF

Info

Publication number
CN101304750A
CN101304750A CNA2006800418105A CN200680041810A CN101304750A CN 101304750 A CN101304750 A CN 101304750A CN A2006800418105 A CNA2006800418105 A CN A2006800418105A CN 200680041810 A CN200680041810 A CN 200680041810A CN 101304750 A CN101304750 A CN 101304750A
Authority
CN
China
Prior art keywords
azithromycin
rosacea
treatment
administration
granulomatous
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2006800418105A
Other languages
English (en)
Chinese (zh)
Inventor
S·姆拉兹-格恩哈德
J·休格曼
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dow Pharmaceutical Sciences Inc
Original Assignee
Dow Pharmaceutical Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dow Pharmaceutical Sciences Inc filed Critical Dow Pharmaceutical Sciences Inc
Publication of CN101304750A publication Critical patent/CN101304750A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/203—Retinoic acids ; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
CNA2006800418105A 2005-11-09 2006-11-08 用于治疗肉芽肿性酒糟鼻的阿奇霉素 Pending CN101304750A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US73484305P 2005-11-09 2005-11-09
US60/734,843 2005-11-09

Publications (1)

Publication Number Publication Date
CN101304750A true CN101304750A (zh) 2008-11-12

Family

ID=38309684

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2006800418105A Pending CN101304750A (zh) 2005-11-09 2006-11-08 用于治疗肉芽肿性酒糟鼻的阿奇霉素

Country Status (10)

Country Link
US (1) US20070105788A1 (https=)
EP (1) EP1945227A4 (https=)
JP (1) JP2009514963A (https=)
CN (1) CN101304750A (https=)
AU (1) AU2006336612A1 (https=)
BR (1) BRPI0617693A2 (https=)
CA (1) CA2626551A1 (https=)
RU (1) RU2008122964A (https=)
WO (1) WO2007086978A2 (https=)
ZA (1) ZA200804896B (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8124123B2 (en) * 2007-09-05 2012-02-28 Dow Pharmaceutical Sciences, Inc. Controlled release azithromycin solid dosages forms
US8143227B2 (en) * 2007-09-05 2012-03-27 Dow Pharmaceutical Sciences, Inc. Azithromycin for treatment of skin disorders
MX2010009493A (es) * 2008-02-28 2010-12-20 Rp Scherer Technologies Llc Proceso para minimizar el polimorfismo.
WO2010006306A1 (en) * 2008-07-10 2010-01-14 Inspire Pharmaceuticals, Inc. Method of treating blepharitis
WO2010085572A1 (en) * 2009-01-23 2010-07-29 Inspire Pharmaceuticals, Inc. Method of treating dry eye disease with azithromycin
RU2425682C1 (ru) * 2010-04-28 2011-08-10 Федеральное государственное учреждение "Уральский научно-исследовательский институт дерматовенерологии и иммунопатологии Федерального агентства по высокотехнологичной медицинской помощи" (ФГУ "УрНИИДВиИ Росмедтехнологий") Способ лечения акне средней степени тяжести
US20130274214A1 (en) * 2010-12-29 2013-10-17 Inspire Pharmaceuticals, Inc. Method for treating blepharitis
JP5986632B2 (ja) 2011-06-28 2016-09-06 メディシス ファーマシューティカル コーポレイション 高用量粘膜接着性メトロニダゾール水系ゲル製剤および細菌性膣炎を治療するためのそれらの使用
WO2014100569A1 (en) * 2012-12-20 2014-06-26 Medicis Pharmaceutical Corporation High dosage topical metronidazole gel formulations

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2446356C (en) * 2001-05-09 2012-07-10 The Regents Of The University Of Michigan Use of compositions for treating rosacea

Also Published As

Publication number Publication date
JP2009514963A (ja) 2009-04-09
EP1945227A2 (en) 2008-07-23
WO2007086978A2 (en) 2007-08-02
EP1945227A4 (en) 2009-09-30
WO2007086978A3 (en) 2007-11-22
AU2006336612A1 (en) 2007-08-02
CA2626551A1 (en) 2007-08-02
US20070105788A1 (en) 2007-05-10
ZA200804896B (en) 2009-07-29
RU2008122964A (ru) 2009-12-20
BRPI0617693A2 (pt) 2011-08-02

Similar Documents

Publication Publication Date Title
Burkman Transdermal hormonal contraception: benefits and risks
WO2021014453A1 (en) Topical jak inhibitor combination compositions for treatment of inflammatory skin conditions
US20040171561A1 (en) Topical formulations for treatment of rosacea
Murray et al. Itraconazole oral solution versus clotrimazole troches for the treatment of oropharyngeal candidiasis in immunocompromised patients
EP1898925A2 (en) Method for the treatment of acne
JP2023503132A (ja) タピナロフおよびｐｄｅ４阻害剤を含む局所用組成物による皮膚障害の治療
JP2010538066A5 (https=)
CN101304750A (zh) 用于治疗肉芽肿性酒糟鼻的阿奇霉素
JP2010538066A (ja) 皮膚疾患治療用アジスロマイシン
WO2021059281A1 (en) Treatment of skin disorders with topical combination compositions comprising tapinarof and an additional ahr activator
Alikhan et al. The role of tetracyclines in rosacea
Mays et al. New antibiotic therapies for acne and rosacea
Diehl et al. Topical steroid-induced perioral dermatitis (TOP STRIPED): case report of a man who developed topical steroid-induced rosacea-like dermatitis (TOP SIDE RED)
JP2011510907A (ja) 尋常性ざ瘡の長期間の処置のためのアダパレンおよび過酸化ベンゾイルの使用
CN101534837B (zh) 用于治疗结节性痤疮的阿奇霉素
CN103596565B (zh) 塞克硝唑在口腔感染治疗中的应用
RU2611375C1 (ru) Способ восстановления функций матки, нарушенных при остром или хроническом воспалении
US20070254025A1 (en) Oral contraceptive and acne medication combination and treatment of acne with reduced side effects
RU2850470C2 (ru) Композиции для местного применения
Cole Dermatologic Therapies
AU2023222825A1 (en) Medication
WO2020188575A1 (en) Treatment of rosacea with topical combination compositions
Awasthi et al. Study of Oral Isotretinoin (13-Cis-Retinoic Acid) Therapy in Patients of Acne Vulgaris
CN107693525A (zh) 阿卡波糖在延缓消化道肿瘤的应用
CA2413923A1 (en) Treatment of inflammatory dermatoses comprising erythromycin or clarythromycin metronidazole and a gastrointestinal hydrogen pump inhibitor

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Open date: 20081112